<a href="https://laohu8.com/S/ALZN">Alzamend Neuro</a> Inc. Issues 243,429 Shares of Common Stock in Conversion of Series B Convertible Preferred Stock
Alzamend Neuro Inc. recently issued 243,429 shares of common stock upon the conversion of approximately 564.76 shares of Series B Convertible Preferred Stock. These transactions occurred between July 23 and July 30, 2025, under an exemption from registration requirements as per Section 4(a)(2) of the Securities Act. As of July 30, 2025, the company had a total of 3,139,861 shares of common stock outstanding. The document does not disclose the other party involved in the transaction or the price of the shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-25-011357), on August 01, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。